December 10, 2017 – By Louis Casey

The stock of CV SCIENCES INCORPORATED (OTCMKTS:CVSI) registered a decrease of 15.83% in short interest. CVSI’s total short interest was 35,100 shares in December as published by FINRA. Its down 15.83% from 41,700 shares, reported previously. With 474,600 shares average volume, it will take short sellers 0 days to cover their CVSI’s short positions.

The stock increased 1.72% or $0.005 during the last trading session, reaching $0.295. About 1.24 million shares traded or 167.97% up from the average. CV Sciences, Inc. (OTCMKTS:CVSI) has 0.00% since December 10, 2016 and is . It has underperformed by 16.70% the S&P500.

CV Sciences, Inc., a life science company, focuses on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol . The company has market cap of $26.70 million. The firm operates through two divisions, Specialty Pharmaceutical and Consumer Product. It currently has negative earnings. It also makes, markets, and sells plant CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods, and vape.

More notable recent CV Sciences, Inc. (OTCMKTS:CVSI) news were published by: which released: “CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL …” on November 21, 2017, also with their article: “CV Sciences, Inc. to Host Third Quarter 2017 Financial Results Conference Call …” published on November 01, 2017, published: “CV Sciences, Inc. Reports Third Quarter 2017 Financial Results” on November 08, 2017. More interesting news about CV Sciences, Inc. (OTCMKTS:CVSI) were released by: and their article: “CV Sciences, Inc. Comments on Latest Research Citing Cannabidiol in Reducing …” published on September 26, 2017 as well as‘s news article titled: “CV Sciences, Inc. to Exhibit at the 2017 Academy of Integrative Health …” with publication date: October 10,

Read More Here...